ZLDPF - Zealand Boehringer liver disease drug survodutide shows fibrosis improvement
2024-06-07 10:21:55 ET
More on Zealand Pharma
- Zealand Pharma: Survodutide Has Potential Beyond Obesity Treatment
- Zealand Pharma releases top-line phase 2 results on weight loss asset dapiglutide
- Zealand Pharma A/S (ZLDPF) Q1 2024 Earnings Call Transcript
- Historical earnings data for Zealand Pharma
- Financial information for Zealand Pharma